BEGIN:VCALENDAR
PRODID:-//ics 70.9054//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/Paris
X-LIC-LOCATION:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP;TZID=Europe/Paris:20260715T062503
SUMMARY:CONGRESS : IMPC Strategic Conference ‘Insights from the Past, Shaping the Future’ 
DTSTART;TZID=Europe/Paris:20260122T000000
DTEND;TZID=Europe/Paris:20260122T235959
UID:20260122280
DESCRIPTION:Join us at the IMPC Strategic Conference to hear about the progress and achievements of the IMPC programme to date (Session I), showcase the extent to which the programme has impacted basic and applied biomedical research (Session II) and confirm the value and justification for continuing the KOMP/IMPC programme and solicit suggestions for future directions and priorities from the IMPC network and the scientific community at large (Session III).
The International Mouse Phenotyping Consortium (IMPC) is a global initiative of 21 research institutions working to systematically knock out and analyze every protein-coding gene in the mouse genome. Since 2011, IMPC has provided open-access data on over 9,000 mouse lines and 95,000+ phenotype annotations, helping researchers worldwide identify disease genes, validate drug targets, and explore gene-disease links. Its resources have contributed to nearly 7,500 scientific publications, including 789 cited in clinical studies, driving advances in understanding and treating human diseases.
🔍 Conference Highlights:


Session I: Progress & achievements of the IMPC


Session II: Impact on basic & applied biomedical research


Session III: Future priorities, community input & the next phase of IMPC/KOMP


 
X
LOCATION:Virtual format 
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR